Home > Companies > Allostera Pharma

General Information
edit

Website	allostera.com/abo...
Category	BioTech
Employees
Description	Biopharmaceutical Company

Offices
edit

Headquarters

1155 Boulevard RenÃ©-LÃ©vesque Ouest
Suite 2701
Montreal, QC H3B 2K8, CAN

See nearby companies

Funding
edit

Series C, 7/09
iNovia Capital
Genesys Capital
BDC Venture Capital
GO Capital Fund

$15.4M

Tags
edit

Allostera Pharma
edit

Allostera Pharma is a preclinical-stage biopharmaceutical company focused on autoimmune diseases such as psoriatic arthritis, gout and type II diabetes.

Milestones
edit

Allostera Pharma received $15.4M in Series C funding. (7/27/09)

Posted 7/27/09 at 4:22pm via onbiovc.com

Videos

Screenshots
edit

Sources

Allostera Pharma, Inc.: Series C $15.4M (onbiovc.com) [edit]

Edit This Page
Last Edited 7/27/09

Revision History

Sharing

External Links

edit

CrunchBase API

JSON Representation of this page.
More API docs »

General Information edit

Offices edit

Funding edit

Tags edit

Allostera Pharma edit

Milestones edit